Shekel Brainweigh Ltd - Aiming for EBITDA Breakeven in Q4 CY23
Shekel Brainweigh Limited (ASX:SBW) reported FY22 sales growth of 14% to US$26.3m, which included 117% growth in Retail Innovation sales to $US2.0m.
288 Views
Shekel Brainweigh Ltd - Sale of Healthweigh Offers Further Valuation Support
Shekel Brainweigh Limited (ASX:SBW) has announced the sale of its Healthweigh business, an own-brand manufacturer/distributor of a range of...
666 Views
Shekel Brainweigh Ltd - Holding Underlying Earnings Despite COGS Pressures/R&D
Shekel Brainweigh Ltd Holding underlying earnings despite COGS pressures/R&D Shekel Brainweigh Limited (ASX:SBW) has reported H1 FY22...
668 Views
Shekel Brainweigh Ltd - Sales Growth to Continue in CY22 on a Number of Fronts
Shekel Brainweigh Ltd Sales growth to continue in CY22 on a number of fronts Shekel Brainweigh Limited (ASX:SBW) has reported CY21 sales...
957 Views
Shekel Brainweigh Ltd: On Track in CY21 and Confidence Building for CY22+
Shekel Brainweigh Ltd On track in CY21 and confidence building for CY22+ Shekel Brainweigh Limited (ASX:SBW) has reported YTD CY21 sales...
711 Views